Archives

by in
Entry Author Date Location
Lotus Pioneers New Treatment for Rare and Disfiguring Disorder, Raises $26 Million From Third Rock 06/30/11 Boston
Lotus Tissue Repair Lands $26,000,000 Series A Financing Round 06/30/11 Boston
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News 06/10/11 Boston
General Compression Pulls In $20.4M, Constellation Nabs $15M, PolyRemedy Wraps Up $20M, & More Boston-Area Deals News 06/08/11 Boston
Constellation Pharma Raises $15M for Epigenetic Drugs 06/06/11 Boston
Constellation Pharmaceuticals Garners $15,000,000 Series B Funding 06/06/11 Boston
Foundation Medicine Teams With Celgene in Quest to Develop Targeted Cancer Treatments 05/17/11 New York
GSK Backs SpringLeaf, Prexa Nabs $7M from Advent & Shire, Acetylon Gets $5M Partnership, & More Boston-Area Life Sciences News 05/13/11 Boston
Foundation Medicine Gets New CEO 05/12/11 Boston
Seventh Sense Biosystems Lands $4,500,000 Series A Financing Round 05/11/11 Boston
eBay Acquires Where, Bluebird Calls In $30M, Humedica Gets $20M, & More Boston-Area Deals News 04/27/11 Boston
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate 04/20/11 Boston
bluebird bio Receives $30,000,000 Series C Financing Round 04/20/11 Boston
Aveo Adds Termeer to Board, Monsanto Partners With Atlas, Biogen Drug Meets Clinical Goal, & More Boston-Area Life Sciences News 04/15/11 Boston
Taris Bio Taps Third Rock Ventures and Previous Backers in $18.3M Financing Round 04/13/11 Boston
Google-ITA Acquisition Advances, Nano Terra Buys Surface Logix, Blueprint Medicines Gets $40M, & More Boston-Area Deals News 04/13/11 Boston
TARIS Biomedical Garners $18,300,000 Series B Round 04/13/11 Boston
Blueprint Medicines Brings In $40M, Led by Third Rock, for Targeted Cancer Therapies 04/11/11 Boston
Blueprint Medicines Lands $40,000,000 Series A Financing Round 04/11/11 Boston
Alnylam Settles One Lawsuit, Hit With Another; Living Proof Raises $16M, Tolerx/GSK Drug Fails to Meet Goal, & More Boston-Area Life Sciences News 03/18/11 Boston
Bluebird Bio Inks AFM Development Deal 03/16/11 Boston
Edimer, Third Rock’s Bet on Rare Diseases, Aims to Begin First Human Tests 03/15/11 Boston
With Sanofi Buyout of Genzyme, Rare Disease Execs Upbeat About Interest in Their Niche 03/03/11 Boston
Flagship VentureLabs, Creating and Spinning Out Cleantech and Life Sciences Startups for 10 Years, Takes the Veil Off 02/17/11 Boston
What Will the Bay Area Biotech Hub Look Like in 20 Years? Xconomy Event To Take the Long View on March 16 02/02/11 San Francisco
Top 10 List of Boston-Area VC Deals for Q4 2010: NinePoint, 1366, Rive, and More 01/24/11 Boston
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug 01/19/11 Boston
Zafgen Weight Loss Drug Shows Promise in First Human Test 01/05/11 Boston
EMC Shells Out $2.25B for Isilon, Cerulean Secures $24M, Kayak Files for IPO, & More Boston-Area Deals News 11/18/10 Boston
Page 5 of 9 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.